CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,144,286
- in 6 filings, $22.1M under 10b5-1 plans
Net −$22,144,286. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-04 | Matsuda Masaru SVP, General Counsel | Shares withheld for taxes | −3,412 | $42.22 | $144K | 20,049 |
| 2021-09-04 | Matsuda Masaru SVP, General Counsel | Exercise or conversion · Restricted Stock Units | −6,883 | 6,883 | ||
| 2021-08-25 | BIZZARI JEAN-PIERRE Director | Sale | −35,000 | $41.01 | $1.4M | 52,544 |
| 2021-08-10 | Torley Helen President and CEO | Exercise or conversion | +50,000 | $14.66 | $733K | 587,160 |
| 2021-08-10 | Torley Helen President and CEO | Sale | −25,138 | $40.42 | $1.0M | 562,022 |
| 2021-08-10 | Torley Helen President and CEO | Sale | −21,914 | $41.47 | $909K | 540,108 |
| 2021-08-10 | Torley Helen President and CEO | Sale | −1,000 | $42.64 | $43K | 539,108 |
| 2021-08-10 | Torley Helen President and CEO | Sale | −400 | $43.26 | $17K | 538,708 |
| 2021-08-10 | Torley Helen President and CEO | Sale | −500 | $44.91 | $22K | 538,208 |
| 2021-08-10 | Torley Helen President and CEO | Sale | −1,048 | $46.11 | $48K | 537,160 |
| 2021-08-10 | Torley Helen President and CEO | Exercise or conversion · Option to Purchase Common Stock | −50,000 | $14.66 | $733K | 300,000 |
| 2021-07-15 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion | +14,685 | $6.55 | $96K | 148,796 |
| 2021-07-15 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion · Option to Purchase Common Stock | −14,685 | 0 | ||
| 2021-07-06 | Torley Helen President and CEO | Exercise or conversion | +50,000 | $14.66 | $733K | 587,160 |
| 2021-07-06 | Torley Helen President and CEO | Sale | −50,000 | $45.97 | $2.3M | 537,160 |
| 2021-07-06 | Torley Helen President and CEO | Exercise or conversion · Option to Purchase Common Stock | −50,000 | $14.66 | $733K | 350,000 |
| 2021-07-01 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion | +40,315 | $6.55 | $264K | 174,426 |
| 2021-07-01 | LaBarre Michael J. SVP, Chief Technical Officer | Sale | −40,315 | $45.70 | $1.8M | 134,111 |
| 2021-07-01 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion · Option to Purchase Common Stock | −40,315 | 14,685 | ||
| 2021-06-07 | Torley Helen President and CEO | Exercise or conversion | +50,000 | $14.66 | $733K | 587,160 |
Page 49 of 59 · 1,177 trades